Hormone Therapy in Breast and Prostate Cancer
There have been enormous changes in the treatment strategies for breast and prostate cancer since the late 1960's, when all hope rested on the development of new and more powerful chemotherapy and endocrine ablation. This book provides an integration of the approaches to treat breast and prostate cancer and is an invaluable aid to understanding the strategic principles currently employed in translation research.
| Author: |
V Craig Jordan, Barrington, J A Furr |
| ISBN: |
0896036731 |
| Publisher: |
Humana Press Inc. |
| Binding: |
Hardcover |
| Year Published: |
Jan 2002 |
| No. of Pages: |
412 |
| Contents: |
PART I. PRECLINICAL ANTIESTROGENS
* Antiestrogens and the Cell Cycle
* Drug Resistance to Antiestrogens
* Mechanisms of Liver Carcinogenesis by Antiestrogens
* The Effects of Triphenylethylene Anti-Estrogens of Parameters of Multistage Hepatocarcinogenesis in the Rat
* Preclinical Studies of Raloxifene and Related Compounds
PART II. ANTIESTROGENS: CLINICAL
* Tamoxifen for the Treatment of Breast Cancer
* Clinical Utility of New Antiestrogens
* Breast Cancer Prevention with Antiestrogens
PART III. INHIBITION OF ESTROGEN SYNTHESIS
* Aromatase Inhibitors
* Clinical Utility of Aromatase Inhibitors
* LHRH Agonists for the Treatment of Breast Cancer: Development and Current Status
PART IV. ANDROGENS AND ANDROGEN WITHDRAWAL
* Molecular Actions of Androgens
* Steroidal Antiandrogensier
* Nonsteroidal Antiandrogens
* LHRH Prostate
* Endocrine Therapy - Future Consolidation |
|
|
|
Please note
Publishers prices can change unexpectedly. If the price of your book has changed we will contact you.
|
